Anafranil 25mg (Clomipramine Hydrochloride Capsule) 25mg

Anafranil 25mg capsules contain clomipramine hydrochloride, a tricyclic antidepressant used to address symptoms of obsessive-compulsive disorder and related conditions. This formulation is designed for oral administration and is stored below 25°C. Ideal for those seeking reliable support for mental health management.

Strength

25mg

Pack Size

30s

Storage

Below 25°C

Manufacturer / TM Owner

SpecGx LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Anafranil 25mg capsules are primarily used to help manage symptoms of obsessive-compulsive disorder (OCD) and may assist with related anxiety or depressive symptoms. They are also prescribed for other mental health conditions as determined by a healthcare provider. This medication belongs to a class of drugs that work on certain brain chemicals to support mood regulation.

Side Effects

Users may experience gradual improvements in mood and reduction of obsessive thoughts over time with consistent use. Some individuals report better sleep patterns and reduced anxiety levels as the medication takes effect. Effects vary by person and may take several weeks to become noticeable.

Precautions & Warnings

Store Anafranil 25mg capsules below 25°C in a dry place away from direct light. Keep the medication out of reach of children and pets to prevent accidental ingestion. Avoid crushing or splitting capsules unless directed by a healthcare professional. Report any unusual symptoms to a doctor promptly.

Avoid Interactions

Anafranil 25mg may interact with other medications, including certain antidepressants, antipsychotics, and drugs that affect heart rhythm. Alcohol and sedatives can increase drowsiness when taken with this medication. Always inform your healthcare provider about all medications and supplements you are using to avoid potential interactions.

Frequently Asked Questions

Anafranil 25mg is primarily used to treat symptoms of obsessive-compulsive disorder (OCD) and may help with related anxiety or depressive symptoms.

Effects may take several weeks to become noticeable as the medication builds up in your system.

Alcohol may increase drowsiness and is not recommended without consulting a healthcare provider.

No, Anafranil 25mg is not classified as a controlled substance but should be used as prescribed.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.